ELSEVIER SCIENCE BV, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
Abstract
none4The therapeutic potential of human pluripotent stem (hPS) cells is threatened by the difficulty to homogeneously direct cell differentiation into specific lineages.
Aims: a) to efficiently derive mature hepatic cells from hPS cells; b) to integrate the specific lineages into a microfluidic platform to obtain a functional liver tissue on a chip.
Methods: Human embryonic stem cells (cell line HES2, National Stem Cell Bank, Madison WI) and induced hPS cells (cell line ADHF#1, iCEMS, Kyoto University) were grown on mouse embryonic fibroblasts (Chemicon, Temecula, CA) and were differentiated on matrigel. Then we developed a multi-stage microfluidic technology to derive mature cells from stem cells. Obtained cells have been characterized both with hepatic markers (alpha-fetoprotein, cytokeratins 18, 19, albumin, CYP3A) and functional tests (glycogen storage, indocyanine green uptake, albumin secretion).
Results: We efficiently differentiated both human embryonic and induced pluripotent stem cells. Two hepatic lineages were obtained: hepatocyte- and cholangiocyte-like cells showing high CYP3A expression, indocyanine uptake, glycogen storage and albumin secretion over a 14-day period. This technology allowed to accurately control hPS cells expansion and fate toward early endoderm commitment, hepatic development and functional maturation on a chip. Compared to conventional culture, microfluidic platform allowed shortening of the time required for differentiation and enhanced functional activity. The proportion between hepatocyte- and cholangiocyte-like cells was 3:1. In particular, we obtained 75% of cells with glycogen storage capacity, whereas the number of CYP3A-positive cells resulted in a 59% of the total, with a 20% increase compared to the standard hepatocytes differentiation. Albumin production was about 40% higher than standard conditions.
Conclusions: The engineerization of pluripotent cell differentiation into hepatic lineages will allow us to further understand the mechanisms involved in tissue development. Moreover, mature hepatic cells fully integrated on a chip could be directly used for temporal-defined toxicological assays and drug screening.noneG.G. Giobbe; F. Michielin; N. Elvassore; A. FloreaniGiobbe, GIOVANNI GIUSEPPE; Michielin, Federica; Elvassore, Nicola; Floreani, Annaros